Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Filament Health Corp (OP: FLHLF ) 0.0373 +0.0023 (+6.57%) Streaming Delayed Price Updated: 12:05 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Filament Health Corp < Previous 1 2 3 Next > Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More April 17, 2024 Via Benzinga Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More March 30, 2024 Via Benzinga Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More March 01, 2024 Via Benzinga Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More February 15, 2024 Via Benzinga 'Rainforests Are Nature's Medicine Cabinets': Biotech Co. Performs Fresh Research On Traditional Plants For Modern Mental Health Challenges January 30, 2024 Via Benzinga Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More January 26, 2024 Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and online course available. Via Benzinga Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More December 27, 2023 President Biden Approves Psychedelics Clinical Trials For Active Military Members President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also... Via Benzinga Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More September 26, 2023 Billionaire Steve Cohen Buys 19M Shares Of Cybin Stock For Psychedelics R&D, Blake Mycoskie $100M Pledge Via Benzinga Topics Economy Exposures Interest Rates Peru's Coca Leaf Will Be Used For Research Toward Treating ADHD, Learn The Details September 21, 2023 Magdalena Biosciences, Jaguar Health (NASDAQ: JAGX) and Filament Health (OTCQB: FLHLF) Via Benzinga Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials August 23, 2023 Starting this October, scientists at Imperial College London’s (ICL) Centre for Psychedelic Research will assess psilocybin-assisted therapy for gambling addiction, noted Psychedelic Spotlight. Via Benzinga Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports August 21, 2023 Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds Via Benzinga Topics Cannabis Economy Exposures Cannabis Interest Rates Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing August 15, 2023 Natural psychedelic drug development company Filament Health (OTCQB: FLHLF) has released its unaudited consolidated, condensed financial results for Q1 2023 ended June 30. Numbers show: Via Benzinga Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More July 24, 2023 Minneapolis Mayor Deprioritizes Psychedelics: 'We Should Be In The Business Of Helping People' Minneapolis Mayor Jacob Frey recently signed an executive order effectively deprioritizing criminal... Via Benzinga Filament Health Uplisting To NASDAQ In A $210M SPAC Deal July 19, 2023 Canadian clinical-stage natural psychedelics company Filament Health (OTCQB: FLHLF) has entered into a definitive agreement with Jupiter Acquisition Corp. (NASDAQ: JAQC), a Special Purpose Acquisition... Via Benzinga Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More July 11, 2023 First Country Allowing MDMA & Psilocybin For Depression, PTSD Makes Headlines On Saturday, July 1, 2023, Australia became the first country to allow physicians to prescribe MDMA to treat post-traumatic... Via Benzinga Filament Supplies Botanical Psilocybin To Canadian Researchers, Inks Global Licensing Deal July 07, 2023 Clinical-stage natural psychedelics company Filament Health (OTCQB: FLHLF) will supply psilocybin for two clinical studies funded by the Canadian Institutes of Health Research (CIHR) operating grants... Via Benzinga UCSF Clinical Trial Shows Promising Results For Naturally-Sourced Psilocybin And Psilocin May 30, 2023 A Phase 1 clinical trial led by the University of California San Francisco (UCSF) assessing research partner Filament Health Corp.’s (OTCQB: FLHLF) botanical psychedelic drug candidates has shown... Via Benzinga Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More May 23, 2023 Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History NY-based biotech platform Terran Biosciences announced the publication of an international PCT patent application... Via Benzinga African Iboga Root Heads To Canadian Company Developing Natural Drugs To Help Treat Addictions May 17, 2023 Clinical-stage natural psychedelics company Filament Health Corp. (OTCQB: FLHLF) has completed the first-ever Nagoya Protocol-compliant import of Tabernanthe iboga root from Gabon to the company’s R&D... Via Benzinga Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More May 15, 2023 Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths... Via Benzinga Filament Health's Q1 2023 Financial Results, Material Uncertainty On The Horizon May 15, 2023 Natural psychedelics drug developer Filament Health Corp. (OTCQB: FLHLF) shared its interim financial results and further business highlights for the first quarter ended March 31, 2023. Via Benzinga Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More April 17, 2023 Revolutionizing Psychedelics: 2 Industry Leaders Team Up On Clinical-Grade MDMA Capsules Via Benzinga Two Psychedelics Companies Collaborate To Provide Clinical-Grade MDMA Capsules For Authorized Patients And Studies April 11, 2023 MDXX-class molecules producer PharmAla Biotech Holdings Inc. Via Benzinga Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill April 03, 2023 The natural psychedelics company responsible for creating the first standardized ayahuasca capsule, Filament Health Corp. Via Benzinga Psychedelic Research Expands In Australia With Palliative Care Partnership & New MDMA Analog Portfolio March 21, 2023 Psyence Partners with iNGENū for Palliative Care Clinical Trial Via Benzinga Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More March 20, 2023 Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered Via Benzinga Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder March 15, 2023 Three companies have provided updates on their efforts to assess different psychedelics for treating a widely varied set of conditions. Via Benzinga Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More February 27, 2023 Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and... Via Benzinga [Video] Revolutionizing Mental Health: Filament Health CEO Discusses The Future Of Psychedelic Medicine February 21, 2023 Cannabis enthusiasts and industry insiders alike will find the latest episode of Benzinga's Cannabis Insider show both informative and engaging. Via Benzinga Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More February 21, 2023 Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.